MetLife Investment Management LLC lifted its holdings in Chemed Co. (NYSE:CHE - Free Report) by 8.5% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 8,511 shares of the company's stock after purchasing an additional 666 shares during the period. MetLife Investment Management LLC owned about 0.06% of Chemed worth $4,509,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently made changes to their positions in CHE. UMB Bank n.a. boosted its stake in shares of Chemed by 300.0% during the 4th quarter. UMB Bank n.a. now owns 52 shares of the company's stock worth $28,000 after acquiring an additional 39 shares during the last quarter. Atala Financial Inc purchased a new position in Chemed during the fourth quarter valued at $29,000. CBIZ Investment Advisory Services LLC grew its holdings in Chemed by 64.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock valued at $30,000 after purchasing an additional 22 shares during the period. Trust Co. of Vermont purchased a new stake in Chemed in the fourth quarter worth about $34,000. Finally, Tortoise Investment Management LLC raised its stake in shares of Chemed by 77.3% in the fourth quarter. Tortoise Investment Management LLC now owns 78 shares of the company's stock worth $41,000 after buying an additional 34 shares during the period. Hedge funds and other institutional investors own 95.85% of the company's stock.
Insider Transactions at Chemed
In related news, CEO Kevin J. Mcnamara sold 1,000 shares of the company's stock in a transaction on Monday, March 31st. The shares were sold at an average price of $615.33, for a total transaction of $615,330.00. Following the sale, the chief executive officer now owns 101,679 shares of the company's stock, valued at $62,566,139.07. This represents a 0.97 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 3.29% of the company's stock.
Chemed Trading Up 1.7 %
Shares of NYSE:CHE traded up $9.58 during midday trading on Monday, reaching $565.32. 115,588 shares of the company were exchanged, compared to its average volume of 98,797. The stock has a market cap of $8.26 billion, a PE ratio of 28.57, a price-to-earnings-growth ratio of 2.15 and a beta of 0.49. The business's fifty day moving average is $587.66 and its two-hundred day moving average is $566.73. Chemed Co. has a one year low of $512.12 and a one year high of $623.61.
Chemed (NYSE:CHE - Get Free Report) last released its quarterly earnings data on Wednesday, April 23rd. The company reported $5.63 EPS for the quarter, beating the consensus estimate of $5.59 by $0.04. The business had revenue of $646.94 million during the quarter, compared to the consensus estimate of $641.78 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The business's revenue was up 9.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $5.20 EPS. As a group, sell-side analysts expect that Chemed Co. will post 21.43 EPS for the current year.
Chemed Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were issued a dividend of $0.50 per share. The ex-dividend date was Monday, February 24th. This represents a $2.00 annualized dividend and a dividend yield of 0.35%. Chemed's dividend payout ratio (DPR) is 9.74%.
Analysts Set New Price Targets
A number of equities analysts have weighed in on CHE shares. Royal Bank of Canada upped their price target on shares of Chemed from $667.00 to $674.00 and gave the stock an "outperform" rating in a research report on Monday. StockNews.com upgraded Chemed from a "hold" rating to a "buy" rating in a research report on Friday, March 7th.
Check Out Our Latest Research Report on CHE
About Chemed
(
Free Report)
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Featured Stories
Before you consider Chemed, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.
While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
